Inbiomotion
Roger is a group leader of the oncology program at the Institute for Research in Biomedicine, Barcelona. Roger developed his professional career primarily in the field of breast cancer metastasis. He holds a bachelor's degree in biochemistry and in business.
Roger received his Ph.D. degree in biochemistry from the University of Barcelona in 2002 and was a postdoctoral fellow at Memorial Sloan-Kettering Cancer Center in Prof. Joan Massagué’s laboratory.
Inbiomotion
Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers.